Google
WWW CareCure Forums

Go Back   CareCure Forums > News Forums > General News

General News General news of interest to the community

Reply
 
Thread Tools Display Modes
Old 11-15-2004, 06:21 PM   #1
Max
Senior Member
 
Max's Avatar
 
Join Date: Jul 2001
Location: Montreal,Province of Quebec, CANADA
Posts: 15,036
Send a message via MSN to Max Send a message via Yahoo to Max Send a message via Skype™ to Max
Can Poor Countries Help Rich Countries Contain Drug Costs?

Can Poor Countries Help Rich Countries Contain Drug Costs?
Libraries
Medical News Keywords
POOR COUNTRIES RICH COUNTRIES DRUG COSTS
Contact Information

Available for logged-in reporters only
Description

Rich countries could follow the lead of poor countries and adopt a more systematic way of selecting medicines for reimbursement, according to a paper.



BMJ 13 November 2004 edition

The concept of essential medicines: lessons for rich countries 329 pp 1169-72 Commentary: The pros and cons of essential medicines for rich countries 329 pp 1172

Newswise - Rich countries could follow the lead of poor countries and adopt a more systematic way of selecting medicines for reimbursement, according to a paper in this week's BMJ.

Rising costs of drugs is universal. From 1998 to 2001, prescription costs in the United States and England increased by 62% and 30% respectively. Yet, since the 1970s, many developing countries have set up national lists of essential medicines, which aim to increase access to medicines, promote better health and contain costs.

Could the essential drugs concept help rich countries to control the rise in drug costs?

Faced with these spiralling costs and increasing demands for quality health care by ageing populations, industrialised countries would do well to consider and adopt these approaches, writes Hans Hogerzeil of the World Health Organization. Essential medicines are not second rate medicines for poor people; they are the most cost-effective treatment for a given condition, he stresses.

Essential drug lists or formularies are already widespread in rich countries, say experts in an accompanying commentary. But there are trade-offs: limitations on choice of drug may save money, but if rigorously applied, some patients will be affected.

Drug lists also need integration into clinical guidelines, which can improve care but not necessarily cut cost, they add. For instance, in the United Kingdom, National Institute for Clinical Excellence guidelines and setting national standards have increased prescribing costs, they add

http://www.newswise.com/articles/view/508250/
Max is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -4. The time now is 09:08 AM.



"CC Wiki" powered by VaultWiki v2.5.0.
Copyright © 2008 - 2013, Cracked Egg Studios.